Cyclin D1 in breast premalignancy and early breast cancer: implications for prevention and treatment.
Zhou
Q
Q
Women's Cancers Section, Laboratory of Pathology, Division of Clinical Sciences, National Cancer Institute, Bethesda, MD 20892, USA.
Hopp
T
T
Fuqua
S A
SA
Steeg
P S
PS
D017209:Apoptosis; D001943:Breast Neoplasms / Q000473:pathology* / Q000517:prevention & control / Q000628:therapy; D002278:Carcinoma in Situ / Q000473:pathology; D018270:Carcinoma, Ductal, Breast / Q000473:pathology; D019938:Cyclin D1 / Q000032:analysis / Q000502:physiology*; D005260:Female; D016193:G1 Phase; D006801:Humans; D019656:Loss of Heterozygosity; D011230:Precancerous Conditions / Q000473:pathology; D020218:Response Elements; D015533:Transcriptional Activation; D014162:Transfection
D019938:Cyclin D1